MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Amyloid deposition affects cognitive manifestations in Parkinson’s disease: The PPMI dataset

    E. Fiorenzato, R. Biundo, D. Cecchin, AC. Frigo, L. Weis, J. Kim, A. Strafella, A. Antonini (Venice, Italy)

    Objective: To investigate the contribution of amyloid depositions to cognitive deficits in the early phase of Parkinson’s disease (PD). Background: Involvement of amyloid deposits is…
  • 2018 International Congress

    Olfactory impairment correlates strongly with limbic blood flow in patients with Parkinson’s disease

    K. Ohta, T. Nakajima (Niigata, Japan)

    Objective: To examine the cerebral blood flow pattern of patients of Parkinson's disease with olfactory disorders, and to investigate the correlation between olfactory impairment and…
  • 2018 International Congress

    Effective Tools for Mild Cognitive Impairment Level I Criteria of Movement Disorder Society: Utility of Screening Tests and Their Interconversion

    RL. Yu, WJ. Lee, JY. Li, YY. Chang, CC. Chen, JJ. Lin, YF. Sung, TK. Lin, RS. Chen, YH. Yang, YW. Yang, SJ. Wang, JL. Hsu, HC. Wang, JL. Fuh (Tainan, Taiwan)

    Objective: Our primary aim was to test the utility of the universally accepted screening tests for detecting mild cognitive impairment (MCI) in patients with Parkinson’s…
  • 2018 International Congress

    The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson’s disease and analysis of relevant factors

    K. Nie, Y. Gao, M. Mei, M. Guo, Z. Huang, L. Wang, J. Zhao, Y. Zhang, L. Wang (Guangzhou, China)

    Objective: To investigate the clinical characteristics, cognitive impairment features, and subgroup types of Parkinson’s disease (PD) patients with mild cognitive impairment and to analyze relevant…
  • 2018 International Congress

    The effects of sensory reward cues on risky decision making in Parkinson’s disease

    M. Cherkasova, P. Surathi, S. Yeung, AJ. Stoessl, M. McKeown, S. Appel-Cresswell, C. Winstanley, J. Barton (Vancouver, BC, Canada)

    Objective: To evaluate the effects of sensory reward cues on risky decision making in unmedicated and medicated Parkinson’s disease (PD). Background: Cue reactivity may play…
  • 2018 International Congress

    Frontal midline theta activity is reduced during cognitive control in Parkinson’s disease

    A. Singh, S. Richardson, N. Narayanan, J. Cavanagh (Iowa City, IA, USA)

    Objective: To investigate the role of frontal theta oscillation during cognitive control in Parkinson's disease (PD). Background: Mid-frontal theta activity underlies cognitive control. These 4-8…
  • 2018 International Congress

    The Association Between Inhibitory Control and Freezing of Gait Severity in Parkinson’s Disease

    E. Bayram, S. Banks, J. Longhurst, B. Bluett (Las Vegas, NV, USA)

    Objective: To investigate the relationship between inhibitory control and freezing of gait (FOG) severity in Parkinson’s disease (PD). Background: Inhibition deficits play a role in…
  • 2018 International Congress

    Affective Theory of Mind Impaired in Parkinson’s Disease: Negative- and Neutral- specific impairments of Emotion State Decoding

    C.H. Tan, S.C. Tu, R.L. Yu (Kaohsiung, Taiwan)

    Objective: The primary aim of this study was to investigate whether the ability to interpret positive, negative, or neutral emotion from a pair of photographed…
  • 2018 International Congress

    Effect of different normative samples and cut-off values on determination of cognitive impairment in the Parkinson’s Progression Marker Initiative

    K. Wyman-Chick, D. Weintraub, P. Martin, L. Erickson, M. (Saint Paul, MN, USA)

    Objective: Compare cognitive performance in participants with Parkinson Disease (PD) utilizing published normative data versus age-stratified norms from the Parkinson’s Progression Marker Initiative (PPMI) healthy…
  • 2018 International Congress

    Predictive factors of fast cognitive decline in Parkinson’s disease after subthalamic stimulation: Myth or reality?

    F. Fluchere, F. Ory-Magne, M. Anheim, V. Rousseau, A. Eusebio, O. Lagha Boukbiza, B. Lemesle, T. Witjas, N. Longato, C. Tranchant, C. Brefel-Courbon, JP. Azulay (Marseille, France)

    Objective: To identify pre-operative factors of fast cognitive decline after subthalamic nucleus stimulation (STN DBS) in Parkinson’s disease (PD). Background: Cognitive outcome after STN DBS…
  • « Previous Page
  • 1
  • …
  • 1134
  • 1135
  • 1136
  • 1137
  • 1138
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley